Advisory Board Meeting, 65750 [2011-27157]

Download as PDF 65750 Federal Register / Vol. 76, No. 205 / Monday, October 24, 2011 / Notices the basic classes of controlled substances listed. Dated: October 3, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–27430 Filed 10–21–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated June 7, 2011, and published in the Federal Register on June 16, 2011, 76 FR 35243, American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug tkelley on DSK3SPTVN1PROD with NOTICES Dated: October 3, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. (Pub. L. 94–409) (5 U.S.C. 552b) [FR Doc. 2011–27424 Filed 10–21–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE I Advisory Board Meeting Time and Date: 8 a.m. to 4:30 p.m. on Wednesday, November 2, 2011, 8 a.m. to 4:30 p.m. on Thursday, November 3, 2011. Place: Stanford University Law School, 550 Nathan Abbott Way, Stanford, California, (650) 724–6258. Matters To Be Considered: Organizational culture and change in the correctional environment; Performance Based Outcomes; Director’s report; Presentations. Contact Person for More Information: Thomas Beauclair, Deputy Director, 202–307–3106, ext. 44254. I I II II II II II II II II II II II II II II II II Morris L. Thigpen, Director. [FR Doc. 2011–27157 Filed 10–21–11; 8:45 am] BILLING CODE 4410–36–M II II II II II II Jkt 226001 DEPARTMENT OF JUSTICE United States Parole Commission Sunshine Act Meeting; Record of Vote of Meeting Closure I, Isaac Fulwood, of the United States Parole Commission, was present at a meeting of said Commission, which started at approximately 11 a.m., on Thursday, September 8, 2011, at the U.S. Parole Commission, 90 K Street, PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 In witness whereof, I make this official record of the vote taken to close this meeting and authorize this record to be made available to the public. Dated: September 15, 2011. Isaac Fulwood, Chairman, U.S. Parole Commission. [FR Doc. 2011–27571 Filed 10–20–11; 4:15 pm] National Institute of Corrections I I I I I The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of 15:34 Oct 21, 2011 NE., Third Floor, Washington, DC 20530. The purpose of the meeting was to discuss four original jurisdiction cases pursuant to 28 CFR 2.27. Four Commissioners were present, constituting a quorum when the vote to close the meeting was submitted. Public announcement further describing the subject matter of the meeting and certifications of the General Counsel that this meeting may be closed by votes of the Commissioners present were submitted to the Commissioners prior to the conduct of any other business. Upon motion duly made, seconded, and carried, the following Commissioners voted that the meeting be closed: Isaac Fulwood, Cranston J. Mitchell, Patricia Cushwa and J. Patricia Wilson Smoot. Schedule Gamma Hydroxybutyric Acid (2010). Ibogaine (7260) ............................ Lysergic acid diethylamide (7315) Tetrahydrocannabinols (7370) ..... Dimethyltryptamine (7435) ........... 1-[1-(2-Thienyl) cyclohexyl] piperidine (7470). Dihydromorphine (9145) ............... Normorphine (9313) ..................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Amobarbital (2125) ....................... Phencyclidine (7471) .................... Phenylacetone (8501) .................. Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Ecgonine (9180) ........................... Hydrocodone (9193) ..................... Heroin (9200) ............................... Meperidine (9230) ........................ Metazocine (9240) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Phenazocine (9715) ..................... Fentanyl (9801) ............................ VerDate Mar<15>2010 American Radiolabeled Chemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated American Radiolabeled Chemicals Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. BILLING CODE 4410–01–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (11–105)] Aerospace Safety Advisory Panel; Charter Renewal National Aeronautics and Space Administration (NASA). ACTION: Notice of renewal and amendment of the charter of the NASA Aerospace Safety Advisory Panel. AGENCY: Pursuant to sections 14(b)(1) and 9(c) of the Federal Advisory Committee Act (Pub. L. 92–463), and after consultation with the Committee Management Secretariat, General Services Administration, the NASA Administrator has determined that a renewal and amendment of the charter of the NASA Aerospace Safety Advisory Panel is in the public interest in connection with the performance of duties imposed on NASA by law. The renewed charter is for a two-year period ending October 13, 2013. It is identical to the previous charter in all respects except it removes references to areas of responsibility that are no longer applicable, updates legal citations, and conforms the text to the most recent Congressional reauthorization for this Federal advisory committee (Pub. L. 111–314 on December 18, 2010). SUMMARY: E:\FR\FM\24OCN1.SGM 24OCN1

Agencies

[Federal Register Volume 76, Number 205 (Monday, October 24, 2011)]
[Notices]
[Page 65750]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27157]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

National Institute of Corrections


Advisory Board Meeting

    Time and Date: 8 a.m. to 4:30 p.m. on Wednesday, November 2, 2011, 
8 a.m. to 4:30 p.m. on Thursday, November 3, 2011.
    Place: Stanford University Law School, 550 Nathan Abbott Way, 
Stanford, California, (650) 724-6258.
    Matters To Be Considered: Organizational culture and change in the 
correctional environment; Performance Based Outcomes; Director's 
report; Presentations.
    Contact Person for More Information: Thomas Beauclair, Deputy 
Director, 202-307-3106, ext. 44254.

Morris L. Thigpen,
Director.
[FR Doc. 2011-27157 Filed 10-21-11; 8:45 am]
BILLING CODE 4410-36-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.